Tapestry Beats on Earnings as Coach Thrives, but Soft Revenue Guidance Weighs on Shares
Tapestry posted Q4 adjusted EPS of $1.32 above consensus, powered by Coach. Kate Spade weakness led to cautious FY27 revenue guidance of $8.4–$8.5B.
NOTRELOAD AI
Accelerant Agrees to $4.4 Billion Take-Private Deal with Thoma Bravo
Shareholders get $20.25/share (49% premium). Expected close: H1 2027.
Morgan Stanley Starts Coverage of Achieve Life Sciences at Overweight with $13 Price Target
Achieve's smoking-cessation drug impressed analysts with strong trial results, putting the company on track for possible FDA approval in 2027.
JD.com Beats Q2 Revenue and Earnings Forecasts, But Stock Falls on Sales Slowdown
JD.com Q2 net revenue fell 2.9% to RMB 346.4 billion but beat forecasts. Profit margins expanded and new business losses narrowed significantly.
Omeros Shares Surge as YARTEMLEA Sales Crush Expectations in Q2
First full quarter of YARTEMLEA delivers $28.5M net product sales and turns Omeros profitable on an adjusted basis in Q2 2026.
Birkenstock Lifts Full-Year Guidance After Strong Q3 Beat as Affluent Shoppers Keep Buying
Birkenstock raises its fiscal 2026 revenue growth outlook to 15% constant currency after strong Q3 results driven by resilient full-price demand from affluent shoppers.